Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil Assessed by 24-Hour Ambulatory Blood Pressure Monitoring in Patients with Essential Hypertension-Reference-Cited by-同舟云学术

Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil Assessed by 24-Hour Ambulatory Blood Pressure Monitoring in Patients with Essential Hypertension

Published:2003 Issue:7 Volume:23 Page:419-430
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clinical Drug Investigation

Author:

Brunner Hans R,Stumpe Klaus O,Januszewicz Andrzej

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Reference27 articles.

1. Implementation of WHO/ISH Guidelines: Role and Activities of WHO

2. Evidence-Based Health Policy—Lessons from the Global Burden of Disease Study

3. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials

4. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of angiotensin receptor blockers for nocturnal blood pressure reduction: a systematic review and meta-analysis;Annals of Medicine;2024-06-03

2. Determination of candesartan or olmesartan in hypertensive patient plasma using UPLC-MS/MS;Translational and Clinical Pharmacology;2021

3. Efficacy and safety of a combination antihypertensive drug (olmesartan plus azelnidipine): “Issues with hypertension studies in real-world practice”;Clinical and Experimental Hypertension;2019-11-22

4. Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China;Current Therapeutic Research;2019

5. Effect of antihypertensive treatment on 24-h blood pressure variability;Journal of Hypertension;2018-04